BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25037345)

  • 21. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulation of ascorbyl palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic gelation processes.
    Yoksan R; Jirawutthiwongchai J; Arpo K
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):292-7. PubMed ID: 20004558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ellagic acid: characterization as substrate of polyphenol oxidase.
    Muñoz-Muñoz JL; Garcia-Molina F; Garcia-Molina M; Tudela J; García-Cánovas F; Rodriguez-Lopez JN
    IUBMB Life; 2009 Feb; 61(2):171-7. PubMed ID: 18925653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial production of ellagic acid and biodegradation of ellagitannins.
    Aguilera-Carbo A; Augur C; Prado-Barragan LA; Favela-Torres E; Aguilar CN
    Appl Microbiol Biotechnol; 2008 Feb; 78(2):189-99. PubMed ID: 18157721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3.
    Luo Y; Teng Z; Wang Q
    J Agric Food Chem; 2012 Jan; 60(3):836-43. PubMed ID: 22224939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of acid and water-soluble chitosan doped fibrous cellulose hemostat wet laid nonwoven web for hemorrhage application.
    Hemamalini T; Vikash N; Brindha P; Abinaya M; Dev VRG
    Int J Biol Macromol; 2020 Mar; 147():493-498. PubMed ID: 31954262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research of the hemostasis effect of chitosan acetic acid solution].
    Tian F; Yang J; Chen S; Kan Y; Ji F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):999-1003. PubMed ID: 16294739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer.
    Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y
    Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine diphosphate-decorated chitosan nanoparticles shorten blood clotting times, influencing the structures and varying the mechanical properties of the clots.
    Chung TW; Lin PY; Wang SS; Chen YF
    Int J Nanomedicine; 2014; 9():1655-64. PubMed ID: 24729701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minocycline encapsulated chitosan nanoparticles for central antinociceptive activity.
    Nagpal K; Singh SK; Mishra DN
    Int J Biol Macromol; 2015 Jan; 72():131-5. PubMed ID: 25111492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study.
    Hosseini SF; Zandi M; Rezaei M; Farahmandghavi F
    Carbohydr Polym; 2013 Jun; 95(1):50-6. PubMed ID: 23618238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method.
    Li FQ; Ji RR; Chen X; You BM; Pan YH; Su JC
    Arch Pharm Res; 2010 Dec; 33(12):1967-73. PubMed ID: 21191762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between ellagic acid and calf thymus DNA studied with flow linear dichroism UV-VIS spectroscopy.
    Thulstrup PW; Thormann T; Spanget-Larsen J; Bisgaard HC
    Biochem Biophys Res Commun; 1999 Nov; 265(2):416-21. PubMed ID: 10558882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficient hemostatic effect of Antarctic krill chitosan is related to its hydration property.
    Wu S; Huang Z; Yue J; Liu D; Wang T; Ezanno P; Ruan C; Zhao X; Lu WW; Pan H
    Carbohydr Polym; 2015 Nov; 132():295-303. PubMed ID: 26256352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles.
    Kim DG; Jeong YI; Choi C; Roh SH; Kang SK; Jang MK; Nah JW
    Int J Pharm; 2006 Aug; 319(1-2):130-8. PubMed ID: 16713152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.